Axonics Inc.’s flagship product is its proprietary SNM system, which includes several innovative features

Axonics Inc.’s flagship product is its proprietary SNM system, which includes several innovative features: The Axonics SNM system features a miniaturized, rechargeable implant that delivers mild electrical pulses to the sacral nerves, which are responsible for bladder and bowel function. This helps to restore normal nerve activity and alleviate symptoms of incontinence. Unlike traditional SNM devices that require frequent surgical replacement of the battery, the Axonics SNM system utilizes a long−lasting rechargeable battery, significantly reducing the need for additional surgeries. The Axonics SNM system is designed to be safe for use during MRI scans, providing patients with more flexibility and access to essential diagnostic procedures. Axonics Inc. is dedicated to advancing its SNM technology through rigorous clinical research and development: The company conducts extensive clinical trials to evaluate the safety, efficacy, and patient satisfaction of its SNM system. These trials provide valuable data to support regulatory approvals and clinical use. Axonics collaborates with leading medical institutions and researchers to further enhance its technology.